NEW YORK (GenomeWeb) – GenMark Diagnostics reported after the close of the market on Tuesday that its revenues in the first quarter were down 29 percent year over year but the firm still beat the consensus analyst estimate on the top and bottom lines.

The company said that for the three months ended March 31, revenues totaled $7.9 million, compared to $11.1 million in the year-ago quarter, and easily surpassing the average analyst estimate of $6.4 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.